Clemastine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 95QN29S1ID. European Medicines Agency schedules Clemastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06648MIG. Clemastine generally arises in the molecular formula C21H26CLNO. The term CLEMASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, no. 11 1970, list 10.) CLEMASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clemastine under HS 29339990 and SITC 51577. As of Q4 2014, CLEMASTINE remains the US FDA Preferred Term for this commodity. Clemastine bears US NLM identifiers UMLS ID C0008929 and NCI Concept Code C61682. SMILES: CLC1CCC(C(OCCC2N(CCC2)C)(C2CCCCC2)C)CC1.